Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
UCMSCs vs BMMSCs in Metabolic Syndrome (CERES)
NCT03059355Phase 2Terminated
- Start
- Apr 2018
- Primary completion
- Mar 2020
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of umbilical cord mesenchymal stem cells, bone marrow mesenchymal stem cells in metabolic syndrome, endothelial dysfunction, chronic inflammation. Started Apr 2018; status: terminated.
02
Drugs
umbilical cord mesenchymal stem cellsbone marrow mesenchymal stem cells
03
Conditions
metabolic syndromeendothelial dysfunctionchronic inflammation
Beyond the preview
Go deeper on NCT03059355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03059355.